The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200-250% tariff on drug imports, which could significantly increase prices and reduce profit margins.   While the tariffs are set to be announced soon, a grace period of 12 to 18 months has been indicated before they take effect. Even with this […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!